Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,488 public trials 2,849 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

NCT03319667

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Investigational Site Number: 8400006 Fort Myers, Florida, United States
  • Investigational Site Number: 8400004 St. Petersburg, Florida, United States
  • Investigational Site Number: 8400007 Kansas City, Missouri, United States
  • Investigational Site Number: 8400005 Nashville, Tennessee, United States
View all 104 locations
View Trial Details
Active, not recruiting

Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

NCT04626024

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations
  • Baylor College of Medicine- McNair Campus Houston, Texas, United States
  • Ben Taub General Hospital Houston, Texas, United States
  • CHI St. Luke's Health Baylor College of Medicine Medical Center Houston, Texas, United States
  • Harris Health System- Smith Clinic Houston, Texas, United States
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

NCT03913949

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • Anhui Procincial hospital Hefei, Anhui, China
  • Henan Provincial Oncology Hospital Zhengzhou, Henan, China
  • Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
  • Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Active, not recruiting

A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain

NCT06125795

Conditions
Behavior, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
Locations
  • HUA - Txagorritxu /ID# 258263 Vitoria-Gasteiz, Alava, Spain
  • Sant Joan de Deu de Manresa /ID# 258266 Manresa, Barcelona, Spain
  • Hospital Universitari Mútua Terrassa /ID# 258267 Terrassa, Barcelona, Spain
  • Hospital Jerez De La Frontera /ID# 258282 Jerez de la Frontera, Cadiz, Spain
View all 25 locations
View Trial Details
Active, not recruiting

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

NCT06035497

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
Locations
  • Local Institution - 0031 Anjo-shi, Aichi-ken, Japan
  • Local Institution - 0011 Nagoya, Aichi-ken, Japan
  • Local Institution - 0024 Toyohashi, Aichi-ken, Japan
  • Local Institution - 0017 Kamogawa, Chiba, Japan
View all 40 locations
View Trial Details
Active, not recruiting

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

NCT06752850

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Classic Hemophilia, +24 more
Locations
  • Sobi Investigational Site Milan, Italy
  • Sobi Investigational Site Naples, Italy
  • Sobi Investigational Site Rozzano, Italy
  • Sobi Investigational Site Oslo, Norway
View Trial Details

Related conditions